Nothing Special   »   [go: up one dir, main page]

IL114459A0 - Method for detecting and/or monitoring the effectiveness of treatment of T cell mediated diseases - Google Patents

Method for detecting and/or monitoring the effectiveness of treatment of T cell mediated diseases

Info

Publication number
IL114459A0
IL114459A0 IL11445995A IL11445995A IL114459A0 IL 114459 A0 IL114459 A0 IL 114459A0 IL 11445995 A IL11445995 A IL 11445995A IL 11445995 A IL11445995 A IL 11445995A IL 114459 A0 IL114459 A0 IL 114459A0
Authority
IL
Israel
Prior art keywords
treatment
effectiveness
monitoring
detecting
cell mediated
Prior art date
Application number
IL11445995A
Other languages
English (en)
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Priority to IL11445995A priority Critical patent/IL114459A0/xx
Publication of IL114459A0 publication Critical patent/IL114459A0/xx
Priority to AU64543/96A priority patent/AU6454396A/en
Priority to EP96923689A priority patent/EP0847281B1/de
Priority to AT96923689T priority patent/ATE235922T1/de
Priority to DE69627161T priority patent/DE69627161T2/de
Priority to JP50531897A priority patent/JP3905126B2/ja
Priority to IL12275696A priority patent/IL122756A/en
Priority to PCT/US1996/011374 priority patent/WO1997002052A1/en
Priority to US08/973,782 priority patent/US6309847B1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • G01N33/505Cells of the immune system involving T-cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • G01N33/56972White blood cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Ecology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Physiology (AREA)
IL11445995A 1995-07-05 1995-07-05 Method for detecting and/or monitoring the effectiveness of treatment of T cell mediated diseases IL114459A0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IL11445995A IL114459A0 (en) 1995-07-05 1995-07-05 Method for detecting and/or monitoring the effectiveness of treatment of T cell mediated diseases
AU64543/96A AU6454396A (en) 1995-07-05 1996-07-02 Method for detecting or monitoring the effectiveness of treament of t cell mediated diseases
EP96923689A EP0847281B1 (de) 1995-07-05 1996-07-02 Verfahren zum nachweis oder zur überwachung der wirksamkeit der behandlung durch t-zellen vermittelter erkrankungen
AT96923689T ATE235922T1 (de) 1995-07-05 1996-07-02 Verfahren zum nachweis oder zur überwachung der wirksamkeit der behandlung durch t-zellen vermittelter erkrankungen
DE69627161T DE69627161T2 (de) 1995-07-05 1996-07-02 Verfahren zum nachweis oder zur überwachung der wirksamkeit der behandlung durch t-zellen vermittelter erkrankungen
JP50531897A JP3905126B2 (ja) 1995-07-05 1996-07-02 T細胞媒介疾患の治療の効力を検出又は監視する方法
IL12275696A IL122756A (en) 1995-07-05 1996-07-02 Method for detecting or monitoring the effectiveness of treatment of t cell mediated diseases
PCT/US1996/011374 WO1997002052A1 (en) 1995-07-05 1996-07-02 Method for detecting or monitoring the effectiveness of treatment of t cell mediated diseases
US08/973,782 US6309847B1 (en) 1995-07-05 1996-07-02 Method for detecting or monitoring the effectiveness of treatment of T cell mediated diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL11445995A IL114459A0 (en) 1995-07-05 1995-07-05 Method for detecting and/or monitoring the effectiveness of treatment of T cell mediated diseases

Publications (1)

Publication Number Publication Date
IL114459A0 true IL114459A0 (en) 1995-11-27

Family

ID=11067728

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11445995A IL114459A0 (en) 1995-07-05 1995-07-05 Method for detecting and/or monitoring the effectiveness of treatment of T cell mediated diseases

Country Status (7)

Country Link
EP (1) EP0847281B1 (de)
JP (1) JP3905126B2 (de)
AT (1) ATE235922T1 (de)
AU (1) AU6454396A (de)
DE (1) DE69627161T2 (de)
IL (1) IL114459A0 (de)
WO (1) WO1997002052A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6022697A (en) * 1996-11-29 2000-02-08 The Regents Of The University Of California Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus
AU2003209623A1 (en) * 2002-02-19 2003-09-09 Yeda Research And Development Co. Ltd. Dual-effect ligands comprising anti-inflammatory hsp peptide epitopes for immunomodulation
WO2006072946A2 (en) * 2005-01-04 2006-07-13 Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science Hsp60, hsp60 peptides and t cell vaccines for immunomodulation
US20070031482A1 (en) * 2005-08-02 2007-02-08 Ceramoptec Industries, Ind. PDT treatment method for cellulites and cosmetic use
JP4283812B2 (ja) * 2006-01-06 2009-06-24 財団法人工業技術研究院 重症筋無力症の診断方法およびそのキット

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996006630A1 (en) * 1994-08-26 1996-03-07 The Regents Of The University Of California Methods and compositions for modulating a t cell response

Also Published As

Publication number Publication date
ATE235922T1 (de) 2003-04-15
WO1997002052A1 (en) 1997-01-23
EP0847281B1 (de) 2003-04-02
DE69627161T2 (de) 2004-02-19
JP2001520740A (ja) 2001-10-30
EP0847281A1 (de) 1998-06-17
EP0847281A4 (de) 2002-01-30
JP3905126B2 (ja) 2007-04-18
DE69627161D1 (de) 2003-05-08
AU6454396A (en) 1997-02-05

Similar Documents

Publication Publication Date Title
NL1008619A1 (nl) Werkwijze voor het meten en aangeven van de mate waarin een persoon beperkt is in activiteiten van het dagelijks leven.
EP1113385A3 (de) Benutzereingabeabtastvorrichtung und Verfahren
DE69940470D1 (de) Vorrichtung und verfahren für die thermometrie
IL126544A0 (en) Analyte assay using particulate labels
CY1108397T1 (el) Αντι-ccr4 αντισωμα και θραυσμα αυτου
EP0445618A3 (en) Device and procedure to measure without contact the surface-contour of an object
EP0702978A3 (de) Vorrichtung zur Behandlung des obstruktiven Atemstillstand im Schlaf
EP0311439A3 (en) Ozone gas sensor and ozone gas detecting device having ozone gas sensor
PT1148816E (pt) Protecções de dentes e métodos de detecção do ranger dos dentes
EP1178536A3 (de) Bildlesegerät
EP0407166A3 (en) Light detecting device and light detection method
IL114459A0 (en) Method for detecting and/or monitoring the effectiveness of treatment of T cell mediated diseases
GR3017975T3 (en) Method for detection of anti-rna-antibodies.
EP1268516A4 (de) Verfahren zur detektion und behandlung von neuronalen krebsarten
FR2651036B1 (fr) Dispositif capteur delivrant des indications de pression et de temperature
ATE345735T1 (de) Kardiovaskulärer monitor
DE60327423D1 (de) Vorrichtung zum nachweis und zur bestätigung von atmung
WO2001029070A8 (en) Modulation of t cell differentiation for the treatment of t helper cell mediated diseases
ATA2289A (de) Vorrichtung zur messung des blutdruckes am menschlichen oder tierischen koerper
JPH03222941A (ja) 入眠判定装置
EP0782863A4 (de) Antikörperreagens zum aufspüren des aneurysma dissecans der aorta sowie dessen verwendung
AU2001266983A1 (en) Adjuvants and processes to induce a specific type of immune response
NZ310301A (en) Method of identifying persons susceptible to group a b-hemolytic streptococci-mediated neuropsychiatric disorders
UA15194A (uk) Спосіб визhачеhhя імуhологічhої чутливості оргаhізму людиhи до металів
JPS6473287A (en) Alarm apparatus